Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
J Hosp Infect. 2023 Oct;140:90-95. doi: 10.1016/j.jhin.2023.07.023. Epub 2023 Aug 9.
To compare intensivist-diagnosed ventilator-associated pneumonia (iVAP) with four established definitions, assessing their agreement in detecting new episodes.
A multi-centric prospective study on pulmonary microbiota was carried out in patients requiring mechanical ventilation (MV). Data collected were used to compare hypothetical VAP onset according to iVAP with the study consensus criteria, the European Centre for Disease Control and Prevention definition, and two versions of the latter adjusted for leukocyte count and fever.
In our cohort of 186 adult patients, iVAPs were 36.6% (68/186, 95% confidence interval 30.0-44.0%), with an incidence rate of 4.64/100 patient-MV-days, and median MV-day at diagnosis of 6. Forty-seven percent of patients (87/186) were identified as VAP by at least one criterion, with a median MV-day at diagnosis of 5. Agreement between intensivist judgement (iVAP/no-iVAP) and the criteria was highest for the study consensus criteria (50/87, 57.4%), but still one-third of iVAP were not identified and 9% of patients were identified as VAP contrary to intensivist diagnosis. VAP proportion differed between criteria (25.2-30.1%).
Caution is needed when evaluating studies describing VAP incidence. Pre-agreed criteria and definitions that capture VAP's evolving nature provide greater consistency, but new clinically driven definitions are needed to align surveillance and diagnostic criteria with clinical practice.
比较重症监护医生诊断的呼吸机相关性肺炎(iVAP)与四个已建立的定义,评估它们在检测新发病例方面的一致性。
对需要机械通气(MV)的患者进行了一项关于肺部微生物组的多中心前瞻性研究。收集的数据用于比较根据 iVAP 假设的 VAP 发病与研究共识标准、欧洲疾病预防控制中心定义以及两种调整白细胞计数和发热的后者版本的差异。
在我们的 186 例成年患者队列中,iVAP 占 36.6%(68/186,95%置信区间 30.0-44.0%),发病率为 4.64/100 患者-MV 天,诊断时 MV 天数中位数为 6.。至少有一个标准将 47%的患者(87/186)诊断为 VAP,诊断时 MV 天数中位数为 5.。重症监护医生判断(iVAP/非 iVAP)与标准之间的一致性以研究共识标准最高(50/87,57.4%),但仍有三分之一的 iVAP 未被识别,9%的患者被诊断为 VAP 与重症监护医生的诊断相反。标准之间的 VAP 比例不同(25.2-30.1%)。
在评估描述 VAP 发病率的研究时需要谨慎。预先商定的标准和定义可以更好地捕捉 VAP 的演变性质,但需要新的临床驱动定义来使监测和诊断标准与临床实践保持一致。